portal
  Home About us Reports Charts News Custom Company Scan  
Report
*
Title Content
 

Tel: 0086-10-82600828, 82600893
Fax: 0086-10-82601570
Email:




Pharmaceutical
Pharmaceutical
Pharmaceutical
  Index>>Life Sciences>>Pharmaceutical

Company Study of Guangxi Wuzhou Zhongheng Group

Published: Aug/2007

Hard Copy  USD $349
Pages:23 Electronic(PDF)  USD $349
Report Code: Enterprisewide  USD $698
Price (Chinese Version + English Version)  USD $649

In 2006, the company received the main business revenue of RMB 321.1685 million, of which the pharmaceutical industry accounted for 62.83%; the profit of main business reached RMB 154.1201 million and, the net profit amounted to RMB 19.6635 million.

Xueshuantong Freeze-Dry Powder for Injection, the company's core pharmaceutical product, is an important variety in cardiovascular and cerebrovascular fields. At present, the company's full-loaded monthly production capacity can not meet the increased market demand, so some products are contracted to Chongqing Yaoyou Pharmaceutical temporarily. It is estimated that the sales volume of Xueshuantong Freeze-Dry Powder for Injection will be 25 million doses in 2007, and 40 million in 2008, 50 million in 2009.

Main Business Structure of Zhongheng Group, 2006


 

Market Pattern of Drugs Used in Hospitals, 2006


 

1 Company profile
1.1 Equity rights transferred by SASAC
1.2 Strategies of the company
1.3 Management and marketing of the company

2. Analysis on cardiovascular drugs
2.1 Analysis on the market
2.2 Traditional Chinese medicine in cardiovascular field
2.3 Market status of the company's Xueshuantong (Freeze-Dry) Powder for Injection

3. Development of the company
3.1 Patent
3.2 Development of the company's pharmaceutical business in 2007
3.3 Status quo of the company's new base
Equity structure of the company
Main business structure of Zhongheng Group, 2006
Market pattern of drugs used in hospitals, 2006
Variation in medicine sales income of Zhongheng Group
Parts of financial indicators of Zhongheng Group
Share and growth rate of sub-classified cardiovascular drugs, 2006
Classification of cardiovascular drugs and main varieties
Comparison of main traditional Chinese injection varieties
Patent application for main inventions of Guangxi Wuzhou Pharmaceuticals (Group) Co., Ltd

China Pharmaceutical Industry Statistics, 2000-2009

Thanks to the stimulus of new medical system reform launched by the government in 2009, the pharmaceuticals industry of China remains steady growth. In the first half of 2009, the output of China’s c...

China Antibiotic Market Report, 2008-2009

From the perspective of industrial scale, China's output and production capacity of antibiotic raw materials ranks the NO.1 in the world. In 2007, China's sales revenue of antibiotic raw materials rea...

China Pharmaceutical Chain Industry Report, 2009

According to the chain drug stores ranking in China in 2009, top 100 enterprises in China pharmaceutical chain industry achieved the sales revenue of RMB57.24 billion in 2008, increasing by RMB13.33 b...

China Vaccine Industry Report, 2008-2009

In the past decade, Chinese vaccine market tripled in scale. China has already become the world’s largest vaccine producer and now has 28 vaccine companies, ranking NO.1 around the globe. It can produ...

US Pharmaceutical Industry Report, 2008-2009

The United States has the largest pharmaceutical industry in the world. In 2007, its pharmaceutical revenue totaled at US$ 315 billion. Global Pharmaceutical Output Value and Profits by Region, 2007...

Indian Pharmaceutical Formulations Industry Report, 2008-2009

India plays an important role in the global pharmaceutical market. In 2005, 2/5 DMFs to FDA were submitted by India. Currently, there are more than 400 kinds of API (Active Pharmaceutical Ingredient) ...

Indian Active Pharmaceutical Ingredients(APIs) Industry Report, 2008-2009

India plays an important part in the global API market. The API output value of India was US $4.1 billion in 2007, with the CAGR as high as 18.81% during 2003-2007. And Indian ranks at the fourth in t...

China Chemical Pharmaceutical Market Report, 2008

By the end of Aug, 2008, the total output value of China’s chemical pharmaceutical industry was CNY 273.272 billion, among which, the total output value of active pharmaceutical ingredient (API) was C...

China Vaccine Market Report, 2007-2009

China is the largest vaccine producer and consumer in the world. According to the statistics of the General Administration of Customs, China's total vaccine import and export volume reached 34,846 ton...

China Pharmaceutical Chain Industry Report, 2007-2008

Pharmaceutical industry is called as "eternal sunrise industry", mainly because of its sustained growth in market demand. The main factors driving the growth in market demand of China's pharmaceutical...

China Animal Vaccine Industry Report, 2006-2009

On Jan. 18th of 2008, Ministry of Agriculture of the People's Republic of China and Ministry of Health of China jointly issued the document to intensify the efforts to carry out the inoculation of rab...

China Chemical Pharmaceutical Industry Report, 2007

Global medicine industry maintains rapid growth continuously.Its scale has started to maintain fast growth since the middle and late in the 20th century. The total output value increased to USD 602 bi...

Company Study of Guangxi Wuzhou Zhongheng Group

In 2006, the company received the main business revenue of RMB 321.1685 million, of which the pharmaceutical industry accounted for 62.83%; the profit of main business reached RMB 154.1201 million and...

China OTC Drug Market Report, 2007

By 2003, the global OTC drug market had reached 63 billion, and China's OTC drugs shared 5.7% of the global market, only behind North America, West Europe and Japan. In 2003, the sales value in China'...

China Pharmaceutical Industry Report, 2006-2007

In Jan-Feb 2007, Product sales revenue of China pharmaceutical industry rose by 17.8% year-on-year and, the gross profits increased by 29.6% from a year earlier. It is noteworthy that the sales of ch...

China Anti-tumor Drugs Market Report, 2007

The anti-tumor drugs market operated well in 2006, and the total sales volume amounted to USD 34.6 billion, up 20.5% from a year earlier, and the growth margin ranked the first place among all the tre...

Economic Operation of Pharmaceutical Industry in China, 2006

In 2006, total industrial output value of China pharmaceutical industry accumulated to RMB532.373 billion, up by 17.89% year on year. Total industrial output value of state-owned economy of pharmaceut...

China Pharmaceutical Industry Report (Merger and Reorganization), 2006-2007

During the Tenth Five-Year Plan period (2001 to 2005), each indicator of the whole pharmaceutical industry greatly exceeded the scheduled; and the industrial output value, industrial added value and t...

2005-2010 www.researchinchina.com All Rights Reserved